Actelion Pharmaceuticals US, Inc.

5000 Shoreline Court
Suite 200
South San Francisco,  CA  94080-1956

United States
  • Booth: 9015

In June 2017, Actelion became part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Actelion's medicines have helped to expand and strengthen Janssen's portfolio with leading, differentiated in-market medicines and promising late-stage compounds. Janssen has added Pulmonary Hypertension as a therapeutic area of focus to maintain the leadership position Actelion has built in this important disease area. Learn more at Follow us on Twitter @actelion_com.